APA aipamena

Jayavaradhan, R., Pillis, D. M., Goodman, M., Zhang, F., Zhang, Y., Andreassen, P. R., & Malik, P. (2019). CRISPR-Cas9 fusion to dominant-negative 53BP1 enhances HDR and inhibits NHEJ specifically at Cas9 target sites. Nat Commun.

Chicago Style aipamena

Jayavaradhan, Rajeswari, Devin M. Pillis, Michael Goodman, Fan Zhang, Yue Zhang, Paul R. Andreassen, and Punam Malik. "CRISPR-Cas9 Fusion to Dominant-negative 53BP1 Enhances HDR and Inhibits NHEJ Specifically At Cas9 Target Sites." Nat Commun 2019.

MLA aipamena

Jayavaradhan, Rajeswari, et al. "CRISPR-Cas9 Fusion to Dominant-negative 53BP1 Enhances HDR and Inhibits NHEJ Specifically At Cas9 Target Sites." Nat Commun 2019.

Kontuz: berrikusi erreferentzia hauek erabili aurretik.